Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€0.68
02.12.23
-
02.12.24
-28.56%
16.07.24

StockNews.com 
02.12.23 50%
sell
U.S. Energy Corp.

Start price
Target price
Perf. (%)
€1.03
02.12.23
-
02.12.24
-6.80%
17.07.24

StockNews.com 
02.12.23 50%
sell
Polar Power Inc

Start price
Target price
Perf. (%)
€0.48
02.12.23
-
02.12.24
-2.40%
16.07.24

StockNews.com 
02.12.23 50%
sell
Altimmune

Start price
Target price
Perf. (%)
€3.45
02.12.23
€1.00
02.12.24
114.68%
09.12.23

overvalued
negative Cash Flow expected
Very little Investments for future growth
Risky balance sheet
Marianka 
02.12.23 50%
sell
Altimmune

Start price
Target price
Perf. (%)
€3.45
02.12.23
€1.00
02.12.24
114.68%
09.12.23

overvalued
negative Cash Flow expected
Probably not worthwhile Investment
Revenue decline/stagnation expected
dimontalban 
02.12.23 70%
buy
Altimmune

Start price
Target price
Perf. (%)
€3.50
01.12.23
€13.77
01.12.24
71.60%
22:26

HC Wainwright 
01.12.23 50%
buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€19.88
01.12.23
€22.00
-
20.12.23

Undervalued
ROE higher than 15% per year
Revenue growth > 30% per year expected
Small Risks for its business
Traumtanz 
01.12.23 50%
sell
Rubicon Technology

Start price
Target price
Perf. (%)
€0.54
30.11.23
-
30.11.24
17.76%
17.07.24

StockNews.com 
30.11.23 50%
buy
First Hydrogen Corp.

Start price
Target price
Perf. (%)
€1.04
29.11.23
€1.00
29.11.24
12.31%
07.12.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Traumtanz 
29.11.23 50%
sell
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.54
29.11.23
-
29.11.24
-23.36%
21.03.24

StockNews.com 
29.11.23 50%
buy
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€0.39
29.11.23
€19.13
29.11.24
-
20.11.23

HC Wainwright 
29.11.23 50%
buy
Trade Desk Inc

Start price
Target price
Perf. (%)
€62.34
28.11.23
€72.83
28.11.24
40.92%
22:26

Truist Financial Co. 
28.11.23 50%
buy
Unilever plc ADR

Start price
Target price
Perf. (%)
€43.80
28.11.23
-
28.11.24
24.07%
22:26

StockNews.com 
28.11.23 50%
sell
Arca Biopharma

Start price
Target price
Perf. (%)
€1.72
28.11.23
-
28.11.24
84.26%
15.07.24

StockNews.com 
28.11.23 50%
sell
Englobal

Start price
Target price
Perf. (%)
€0.23
28.11.23
-
28.11.24
-6.96%
30.11.23

StockNews.com 
28.11.23 50%
buy
EuroDry

Start price
Target price
Perf. (%)
€16.30
28.11.23
€27.33
28.11.24
25.15%
17.07.24

Alliance Global Partners 
28.11.23 50%
sell
Inotiv Inc.

Start price
Target price
Perf. (%)
€2.46
28.11.23
€0.000
28.11.24
26.83%
09.12.23

Risky Investment
EBIT decline > 20% expected
Decining EBIT margin than peer group
High valuation
Marianka 
28.11.23 50%
buy
Gevo Inc.

Start price
Target price
Perf. (%)
€1.00
27.11.23
€2.01
27.11.24
-39.95%
22:26

Stifel Nicolaus 
27.11.23 50%
buy
Baidu Inc. A ADR

Start price
Target price
Perf. (%)
€113.20
27.11.23
€136.91
27.11.24
-26.33%
22:26

Susquehanna 
27.11.23 50%
buy
Sonnet Biotherapeutics Holdings Inc.

Start price
Target price
Perf. (%)
€0.18
27.11.23
€6.40
27.11.24
-
20.11.23

LADENBURG THALM/SH SH 
27.11.23 50%
sell
Lipocine Inc.

Start price
Target price
Perf. (%)
€3.67
27.11.23
-
27.11.24
0.00%
09.02.24

StockNews.com 
27.11.23 50%
sell
Recon Technology Ltd.

Start price
Target price
Perf. (%)
€0.24
27.11.23
-
27.11.24
-62.95%
30.04.24

StockNews.com 
27.11.23 50%
buy
Gevo Inc.

Start price
Target price
Perf. (%)
€1.05
27.11.23
€8.00
27.11.24
4.87%
09.12.23

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Revenue decline/stagnation expected
EBIT decline/stagnation expected
dimontalban 
27.11.23 50%
buy
Consolidated Uranium Inc.

Start price
Target price
Perf. (%)
€1.33
27.11.23
€3.00
27.11.24
0.00%
09.12.23

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
dimontalban 
27.11.23 60%
sell
Consolidated Uranium Inc.

Start price
Target price
Perf. (%)
€1.33
27.11.23
-
27.11.24
0.00%
08.12.23

Could be very worthwhile Investment >20% year
robertinio 
27.11.23 100%